These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18744)

  • 1. Lack of effect of chronically administered thyrotropin-releasing hormone (TRH) on regional rat brain tyrosine hydroxylase activity.
    Nemeroff CB; Diez JA; Bissette G; Prange AJ; Harrell LE; Lipton MA
    Pharmacol Biochem Behav; 1977 Apr; 6(4):467-9. PubMed ID: 18744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone.
    Agarwal RA; Rastogi RB; Singhal RL
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):743-52. PubMed ID: 12549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a TRH analog (DN-1417) on tyrosine hydroxylase activity in discrete areas of rat brain.
    Yokoo H; Nakahara T; Uchimura H; Matsumoto T; Hirano M
    Kurume Med J; 1983; 30 Suppl():S37-43. PubMed ID: 6148453
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of TRH analog (DN-1417) on tyrosine hydroxylase activity in mesocortical, mesolimbic and nigrostriatal dopaminergic neurons of rat brain.
    Yokoo H; Nakahara T; Matsumoto T; Inanaga K; Uchimura H
    Peptides; 1987; 8(1):49-53. PubMed ID: 2883633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of TRH and histidyl-proline diketopiperazine (cyclo(His-Pro] on catecholamine secretion].
    Miyamori C; Murata A; Imura E; Sato T
    Nihon Naibunpi Gakkai Zasshi; 1989 Nov; 65(11):1226-38. PubMed ID: 2512185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MK-771 enhances the turnover of norepinephrine in brain.
    Rastogi RB; Singhal RL
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):187-90. PubMed ID: 6115460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase of tyrosine hydroxylase activity after reserpine: evidence for the selective response of noradrenergic neurons.
    Sorimachi M
    Brain Res; 1975 Dec; 99(2):400-4. PubMed ID: 241464
    [No Abstract]   [Full Text] [Related]  

  • 8. Reserpine effect on the axonal transport of dopamine-beta-hydroxylase and tyrosine hydroxylase in rat brain.
    Levin BE
    Exp Neurol; 1981 Apr; 72(1):99-112. PubMed ID: 6162666
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of TRH on hypothalamic catecholaminergic and serotoninergic neurons.
    Grosman M; Rubio MC
    Gen Pharmacol; 1987; 18(4):369-72. PubMed ID: 2886396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of reserpine on activities and amounts of tyrosine hydroxylase and dopamine-beta-hydroxylase in catecholamine neuronal systems in rat brain.
    Reis DJ; Joh TH; Ross RA
    J Pharmacol Exp Ther; 1975 Jun; 193(3):775-84. PubMed ID: 239215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic thyrotropin releasing hormone (TRH) administration on TRH receptors and muscarinic cholinergic receptors in CNS.
    Ogawa N; Mizuno S; Nukina I; Tsukamoto S; Mori A
    Brain Res; 1983 Mar; 263(2):348-50. PubMed ID: 6301651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of reserpine and haloperidol on tyrosine hydroxylase activity in the brains of aged rats.
    Fine MI; Masserano JM; Weiner N
    Life Sci; 1986 Jul; 39(3):235-41. PubMed ID: 2874461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thyrotropin-releasing hormone content of rat brain and hypothalamus: results of endocrine and pharmacologic treatments.
    Kardon F; Marcus RJ; Winokur A; Utiger RD
    Endocrinology; 1977 Jun; 100(6):1604-9. PubMed ID: 140045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term changes in rat brain tyrosine hydroxylase following reserpine treatment: a quantitative immunochemical analysis.
    Labatut R; Buda M; Bérod A
    J Neurochem; 1988 May; 50(5):1375-80. PubMed ID: 2896228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyrotropin-releasing hormone is not required for thyrotropin secretion in the perinatal rat.
    Theodoropoulos T; Braverman LE; Vagenakis AG
    J Clin Invest; 1979 Apr; 63(4):588-94. PubMed ID: 108290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of thyroid hormone, TRH and TSH on pro-TRH concentrations in various organs of rats.
    Mitsuma T; Hirooka Y; Yuasa K; Nogimori T
    Endocrinol Exp; 1990 Dec; 24(4):395-402. PubMed ID: 2128932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on thyrotropin releasing hormone in cerebellar ataxia mutant mouse brain.
    Fukuma N; Nihei N
    Life Sci; 1986 May; 38(18):1625-31. PubMed ID: 2871469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole brain tyrosine hydroxylase activity during the development of deoxycorticosterone acetate-1% sodium chloride-induced hypertension in rats.
    Jackson N; Gulliver PA; Dean HG
    J Pharm Pharmacol; 1981 Jul; 33(7):445-50. PubMed ID: 6115031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a critical period for postnatal elevation of brain tyrosine hydroxylase activity resulting from reserpine administration during embryonic development.
    Lydiard RB; Sparber SB
    J Pharmacol Exp Ther; 1974 May; 189(2):370-9. PubMed ID: 4151393
    [No Abstract]   [Full Text] [Related]  

  • 20. Source and physiological significance of plasma 3,4-dihydroxyphenylalanine in the rat.
    Eisenhofer G; Goldstein DS; Ropchak TG; Kopin IJ
    J Neurochem; 1988 Oct; 51(4):1204-13. PubMed ID: 2901461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.